8.17 USD
-0.05 (-0.61%)
8.17 USD
0 (0%)
Taking everything into account, KMDA scores 6 out of 10 in our fundamental rating. KMDA was compared to 525 industry peers in the Biotechnology industry. KMDA scores excellent on profitability, but there are some minor concerns on its financial health. KMDA scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings would make KMDA suitable for value investing!
1. Profitability
1.1 Basic Checks
- In the past year KMDA was profitable.
- In the past year KMDA had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: KMDA reported negative net income in multiple years.
- KMDA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 5.42%, KMDA belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 7.72%, KMDA belongs to the top of the industry, outperforming 91.62% of the companies in the same industry.
- KMDA's Return On Invested Capital of 6.67% is amongst the best of the industry. KMDA outperforms 93.14% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for KMDA is significantly below the industry average of 18.07%.
- The last Return On Invested Capital (6.67%) for KMDA is above the 3 year average (2.97%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 7.72% | ||
| ROIC | 6.67% |
ROA(3y)1.79%
ROA(5y)2.56%
ROE(3y)2.5%
ROE(5y)3.16%
ROIC(3y)2.97%
ROIC(5y)N/A
1.3 Margins
- KMDA has a Profit Margin of 11.70%. This is amongst the best in the industry. KMDA outperforms 91.81% of its industry peers.
- In the last couple of years the Profit Margin of KMDA has declined.
- KMDA has a Operating Margin of 15.89%. This is amongst the best in the industry. KMDA outperforms 93.71% of its industry peers.
- In the last couple of years the Operating Margin of KMDA has declined.
- KMDA has a Gross Margin of 43.75%. This is in the better half of the industry: KMDA outperforms 74.48% of its industry peers.
- KMDA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.89% | ||
| PM (TTM) | 11.7% | ||
| GM | 43.75% |
OM growth 3YN/A
OM growth 5Y-7.07%
PM growth 3YN/A
PM growth 5Y-13.08%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KMDA is destroying value.
- KMDA has more shares outstanding than it did 1 year ago.
- KMDA has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for KMDA is higher compared to a year ago.
2.2 Solvency
- KMDA has an Altman-Z score of 3.64. This indicates that KMDA is financially healthy and has little risk of bankruptcy at the moment.
- KMDA has a Altman-Z score of 3.64. This is in the better half of the industry: KMDA outperforms 70.67% of its industry peers.
- KMDA has a debt to FCF ratio of 0.59. This is a very positive value and a sign of high solvency as it would only need 0.59 years to pay back of all of its debts.
- KMDA's Debt to FCF ratio of 0.59 is amongst the best of the industry. KMDA outperforms 95.05% of its industry peers.
- A Debt/Equity ratio of 0.04 indicates that KMDA is not too dependend on debt financing.
- KMDA's Debt to Equity ratio of 0.04 is in line compared to the rest of the industry. KMDA outperforms 42.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.59 | ||
| Altman-Z | 3.64 |
ROIC/WACC0.77
WACC8.65%
2.3 Liquidity
- A Current Ratio of 4.02 indicates that KMDA has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 4.02, KMDA is in line with its industry, outperforming 48.00% of the companies in the same industry.
- KMDA has a Quick Ratio of 2.25. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
- KMDA's Quick ratio of 2.25 is on the low side compared to the rest of the industry. KMDA is outperformed by 70.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.02 | ||
| Quick Ratio | 2.25 |
3. Growth
3.1 Past
- KMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.57%, which is quite impressive.
- The earnings per share for KMDA have been decreasing by -13.60% on average. This is quite bad
- KMDA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.36%.
- The Revenue has been growing slightly by 4.82% on average over the past years.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
3.2 Future
- KMDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.48% yearly.
- Based on estimates for the next years, KMDA will show a quite strong growth in Revenue. The Revenue will grow by 10.57% on average per year.
EPS Next Y44.17%
EPS Next 2Y31.88%
EPS Next 3Y29.48%
EPS Next 5YN/A
Revenue Next Year12.37%
Revenue Next 2Y11.88%
Revenue Next 3Y10.57%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 22.69 indicates a rather expensive valuation of KMDA.
- 94.29% of the companies in the same industry are more expensive than KMDA, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 27.38. KMDA is around the same levels.
- KMDA is valuated rather expensively with a Price/Forward Earnings ratio of 18.07.
- Based on the Price/Forward Earnings ratio, KMDA is valued cheaply inside the industry as 94.67% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.29, KMDA is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.69 | ||
| Fwd PE | 18.07 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, KMDA is valued cheaply inside the industry as 97.52% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, KMDA is valued cheaply inside the industry as 94.48% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.13 | ||
| EV/EBITDA | 9.54 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of KMDA may justify a higher PE ratio.
- KMDA's earnings are expected to grow with 29.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y31.88%
EPS Next 3Y29.48%
5. Dividend
5.1 Amount
- KMDA has a Yearly Dividend Yield of 2.45%.
- Compared to an average industry Dividend Yield of 1.18, KMDA pays a better dividend. On top of this KMDA pays more dividend than 98.48% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.85, KMDA pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.45% |
5.2 History
- KMDA does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y31.88%
EPS Next 3Y29.48%
8.17
-0.05 (-0.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10 2025-11-10/bmo
Earnings (Next)03-03 2026-03-03/bmo
Inst Owners11.42%
Inst Owner Change0%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap471.25M
Revenue(TTM)174.79M
Net Income(TTM)20.45M
Analysts84.44
Price Target13.26 (62.3%)
Short Float %0.24%
Short Ratio0.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.45% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.52%
Min EPS beat(2)-4.61%
Max EPS beat(2)45.66%
EPS beat(4)3
Avg EPS beat(4)17.85%
Min EPS beat(4)-4.61%
Max EPS beat(4)45.66%
EPS beat(8)6
Avg EPS beat(8)19.32%
EPS beat(12)9
Avg EPS beat(12)7.95%
EPS beat(16)10
Avg EPS beat(16)-82.64%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)1.07%
PT rev (1m)-11.86%
PT rev (3m)-18.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.5%
EPS NY rev (1m)2.08%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.69 | ||
| Fwd PE | 18.07 | ||
| P/S | 2.7 | ||
| P/FCF | 25.13 | ||
| P/OCF | 16.25 | ||
| P/B | 1.78 | ||
| P/tB | 2.01 | ||
| EV/EBITDA | 9.54 |
EPS(TTM)0.36
EY4.41%
EPS(NY)0.45
Fwd EY5.53%
FCF(TTM)0.33
FCFY3.98%
OCF(TTM)0.5
OCFY6.15%
SpS3.03
BVpS4.59
TBVpS4.07
PEG (NY)0.51
PEG (5Y)N/A
Graham Number6.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 7.72% | ||
| ROCE | 8.44% | ||
| ROIC | 6.67% | ||
| ROICexc | 8.54% | ||
| ROICexgc | 9.66% | ||
| OM | 15.89% | ||
| PM (TTM) | 11.7% | ||
| GM | 43.75% | ||
| FCFM | 10.73% |
ROA(3y)1.79%
ROA(5y)2.56%
ROE(3y)2.5%
ROE(5y)3.16%
ROIC(3y)2.97%
ROIC(5y)N/A
ROICexc(3y)3.77%
ROICexc(5y)N/A
ROICexgc(3y)8.9%
ROICexgc(5y)N/A
ROCE(3y)3.76%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.21%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.77%
OM growth 3YN/A
OM growth 5Y-7.07%
PM growth 3YN/A
PM growth 5Y-13.08%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.59 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 67.04% | ||
| Cap/Sales | 5.86% | ||
| Interest Coverage | 35.6 | ||
| Cash Conversion | 67.35% | ||
| Profit Quality | 91.69% | ||
| Current Ratio | 4.02 | ||
| Quick Ratio | 2.25 | ||
| Altman-Z | 3.64 |
F-Score7
WACC8.65%
ROIC/WACC0.77
Cap/Depr(3y)51.55%
Cap/Depr(5y)66.64%
Cap/Sales(3y)4.62%
Cap/Sales(5y)4.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
EPS Next Y44.17%
EPS Next 2Y31.88%
EPS Next 3Y29.48%
EPS Next 5YN/A
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
Revenue Next Year12.37%
Revenue Next 2Y11.88%
Revenue Next 3Y10.57%
Revenue Next 5YN/A
EBIT growth 1Y56.49%
EBIT growth 3YN/A
EBIT growth 5Y-2.59%
EBIT Next Year134.37%
EBIT Next 3Y44.92%
EBIT Next 5YN/A
FCF growth 1Y941.67%
FCF growth 3YN/A
FCF growth 5Y7.92%
OCF growth 1Y336.09%
OCF growth 3YN/A
OCF growth 5Y11.73%
KAMADA LTD / KMDA FAQ
Can you provide the ChartMill fundamental rating for KAMADA LTD?
ChartMill assigns a fundamental rating of 6 / 10 to KMDA.
What is the valuation status for KMDA stock?
ChartMill assigns a valuation rating of 7 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.
Can you provide the profitability details for KAMADA LTD?
KAMADA LTD (KMDA) has a profitability rating of 7 / 10.
How financially healthy is KAMADA LTD?
The financial health rating of KAMADA LTD (KMDA) is 6 / 10.